Ignite Creation Date:
2024-05-06 @ 3:53 AM
Last Modification Date:
2024-10-26 @ 11:40 AM
Study NCT ID:
NCT02393859
Status:
COMPLETED
Last Update Posted:
2024-05-29
First Post:
2015-03-16
Brief Title:
Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk HR First Relapse B-precursor Acute Lymphoblastic Leukemia ALL
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-10
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-21
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-16
First Submit QC Date:
March 19 2015
Study First Post Date:
2015-03-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-07-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-10
Last Update Post Date:
2024-05-29
Last Update Post Date Type:
ACTUAL